Healthcare

AlzeCure gets Presentation Accepted on Disease-Modifying Effects of ACD856 at Alzheimer’s Conference

STOCKHOLM, SE / ACCESSWIRE / September 26, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…

8 months ago

FendX Engages Independent Trading Group (ITG), Inc. for Market Making Services and Engages Longtable Capital Partners for IR Services

Oakville, Ontario--(Newsfile Corp. - September 25, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or…

8 months ago

NextGen Healthcare Supports Athletico Physical Therapy’s Growing Footprint

One of Nation’s Largest Physical Therapy Networks Enters New Markets, Doubles Down on Healthcare Software SolutionREMOTE-FIRST COMPANY/CHICAGO--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare,…

8 months ago

Florence Healthcare Acquires VersaTrial to Accelerate Clinical Research Site Enablement

Florence Healthcare, the leading provider of Site Enablement Platforms for clinical trials, announced today that it has acquired VersaTrial, a…

8 months ago

DirectTrust Releases New 2024 Accreditation Criteria Versions for Public Review through November 28

Criteria enhancements include those for 19 existing programs; updates address the elimination of criteria redundancies across several programs as well…

8 months ago

myBenefits.ai Welcomes Edward Marx and Paolo Zambito to the Advisory Team

PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--myBenefits.ai, an AI-powered platform for personalized post-discharge instructions, streamlined communication, and convenient healthcare support, announced today that…

8 months ago

HPC Announced ‘HPC ROCKS COEUR D’ALENE’ Event During 2023 MCRA Annual Conference

HPC recently hosted its annual 'HPC ROCKS COEUR D'ALENE' Event at the 2023 MCRA Annual Conference.COEUR D'ALENE, ID / ACCESSWIRE…

8 months ago

Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement

Proceeds to fund company's clinical trials, commercial product launch, and working capital Initial conversion price set at $1.50 per shareSAN…

8 months ago

New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Living with Seborrheic Dermatitis

WESTLAKE VILLAGE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage company focused on…

8 months ago

Scilex Holding Company announces the State of Indiana Medicaid will add Elyxyb as a preferred agent to its preferred drug list (PDL) effective October 1, 2023

PALO ALTO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating…

8 months ago